[Abstract] Over the past decade, in vivo bioluminescent imaging has emerged as a non-invasive and sensitive tool for studying ongoing biological processes within living organisms (Contag et al., 1997; Contag et al., 1998) . Based on the detection and quantitation of the photons produced by the oxidation of luciferin by luciferase enzymes (Harvey, 1927) , this technique has proved to be particularly useful in analyzing cancerous cells and monitoring tumor growth (Edinger et al., 1999; Sweeney et al., 1999; Vidal et al., 2015) , providing a cost-effective insight into how the disease progresses in vivo, without the need of serial sacrifice of animals. This protocol describes in detail the procedure of obtaining luciferase-tagged tumors in immunocompromised mice that can be studied by bioluminescent imaging through the use of an IVIS Spectrum imager.
Figure 1. Schematic representation of the steps required to successfully tag cells with luciferase and perform in vivo imaging

Procedure
A. Bacterial transformation
Artificially constructed plasmids are the most commonly used vectors for introducing foreign DNA into bacterial cells. In this protocol, we used the commercial plasmid Lenti CMV Puro LUC, which contains the firefly luciferase gene, and was transformed into a culture of Stbl3 competent cells.
1. Transfer 50 μl of Stbl3 competent cells in a 1.5 ml Eppendorf tube placed on ice .
2. Add between 100 ng and 500 ng of plasmid into the tube and resuspend with Stbl3 competent cells (pipet to resuspend, do not use vortex).
3. Incubate the tube on ice for 30 min, gently resuspend every 10 min.
4. Place the tube in a thermo-block for exactly 45 sec at 42 °C, and immediately put back into ice for 2 min.
5. Add 800 μl of LB-Medium with no antibiotic into the tube, and gently resuspend the sample with a pipet (do not use vortex).
6. Grow up bacteria in a shaker incubator at 37 °C speed 200 rpm for 2-3 h.
7. Plate 100 µl of transformation mixture on LB-agar plates with 100 μg/ml of ampicillin.
8. Place plate in an incubator at 37 °C overnight.
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10. Incubate overnight at 37 °C in a shaker incubator at a speed of 200 rpm.
B. DNA extraction
There are several methods that can be used to purify plasmid DNA depending on the size of the bacterial culture and its corresponding plasmid yield, and a handful of kits available from varying manufacturers to do it. Here, we perform a minipreparation (miniprep) using the QIAprep Spin Miniprep Kit, which allows the isolation of a small-scale sample of up to 20 μg plasmid DNA from the transformed bacteria. Briefly, in this protocol the isolation of DNA from bacteria relies upon the use of columns and centrifugation steps in which DNA is sheared, extracted, and precipitated. Follow protocol of the manufacturer.
C. Transfection of DNA into viral packaging cells
Depending on the plasmid, several packaging cells can be used to generate the desired virus. In this protocol, we used Phoenix-Ampho cells, which are a second-generation retrovirus producer cell line that is also capable of a long-term stable production of lentiviruses when helper DNA (CMV and DMV) is present. Helper DNA encodes viral genes that increase viral replication and packaging.
Seed 3 x 10
6 Phoenix-Ampho cells in 8 ml of RPMI supplemented with 10% FBS and 1%
PenStrep in a 10 cm 2 culture plate 24 h before transfection.
2. In a first 1.5 ml Eppendorf tube, add 6 μg of DNA, 3 μg of each helper (CMV and DMV)
and fill up to 250 μl of 150 mM NaCl (per sample to transfect).
3. In a second 1.5 ml tube add 24 μl of jetPEI and 226 μl of 150 mM NaCl (per sample to transfect).
4. Vortex the tubes for 10 sec.
5. Add the Jetpei + NaCl into the Eppendorf tube with the DNA and vortex for 10 sec.
6. Incubate mixture for 15 min at room temperature.
7. Remove media of plate and add 9.5 ml of fresh RPMI supplemented with 10% FBS and 1% PenStrep to Phoenix-Ampho cells (see step C1).
8. Add 500 μl drop by drop, of the mixture (step C5) to the plate and incubate overnight at 37 °C. http://www.bio-protocol.org/e1762
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D. Viral particle cell infection
The viral particles produced in the previous step are used to infect cells. Virus will infect cells which hold a receptor that the virus can bind to. Therefore, the efficiency of viral infection will greatly depend on the cell type. In this protocol, we infected 70% confluent 22Rv1 prostate cancer cells growing in 10 cm 2 culture dishes with 10 ml of media.
1. Add Polybrene to cultured cells to a final concentration of 10 μg/ml.
Note: Polybrene is an efficient infection reagent used to introduce viral vectors into mammalian cells. Polybrene acts by neutralizing the charge repulsion between virions and the cell surface (Davis et al., 2004).
2. Using a 5 ml pipet, add 4 ml of filtered viral particles to cultured cells.
3. Centrifuge 10 cm 2 plate at 250 x g for 5 min.
Note: This step helps the physical contact of viruses with surface of cells increasing infection efficiency.
4. Place cells in 37 °C, 5% CO2 incubator for 18-24 h.
Note: Infection efficiency can be affected by incubation time. Troubleshooting using different incubation times can be performed to identify most efficient incubation time
for a specific cell type.
Aspirate the medium and add 10 ml of fresh RPMI supplemented with 10% FBS and 1%
PenStrep. Incubate at 37 °C for 24 h.
Select infected 22Rv1 prostate cancer cells by adding Puromycin at a final
concentration of 2 µg/ml to culture media.
Note: Puromycin concentration will depend on cell type.
7.
Replace medium containing Puromycin every 3 days. Cells that have incorporated the pLenti CMV Puro LUC will grow up under antibiotic selection conditions.
Check that the cells have incorporated the luciferase plasmid.
Note: Multiple methods can be used to test successful luciferase. Examples are detection of luciferase by PCR or measuring luciferase activity upon D-Luciferin
exposure (see Figure 2 ).
E. Injection of luciferase-tagged cells into immunocompromised mice
In this protocol, we performed subcutaneous injection of luciferase-tagged tumor cells.
However, alternative injection sites such as the mouse prostate (orthotropic), which promotes a prostate microenvironment, and subrenal capsule injection, which enhances successful engraftment and preserves tumor heterogeneity, can be performed based on http://www.bio-protocol.org/e1762
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2. Count cells using a hemocytometer.
3. Mix 10 6 cells suspended in 100 μl of RPMI supplemented with 100 μl of extracellular matrix (1:1 ratio) and place on ice.
4. Anesthetize mice prior to subcutaneous injection in a chamber supplying 5% (v/v) inhaled isoflurane in 1 L/min of oxygen.
5. Using a 25 gauge needle and a 1 ml syringe, inject 250 μl of cell and extracellular matrix suspension subcutaneously into the flanks of immunodeficient NSG mice.
F. Bioluminescence imaging
The IVIS Spectrum imager expresses the bioluminescent signal in photons per second and displays it as an intensity map. The luminescence, which is the consequence of the photon flux emitted by the luciferase-expressing cells, directly correlates to the size of the tumor and can be measured at the site of injection using a region of interest (ROI) tool.
The optical emission image can be adjusted to provide optimal contrast and resolution without affecting quantitation using the Living Image © in vivo imaging software.
1. Prepare a fresh stock solution of D-Luciferin at 15 mg/ml in 1x DPBS.
2. Anesthetize the mice using isoflurane vaporizer and place them inside the camera box of the IVIS Spectrum imager.
3. Run a background image of the mice. 
